Neurological Complications and Sequelae of Ebola Virus Disease

Current Infectious Disease Reports

Volumn 19, Issue 5, 2017, Pages

  Billioux, Bridgette Jeanne ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Ebola virus disease; Neurological sequelae; Viral persistence

Indexed keywords

ACUTE DISEASE; AMNESIA; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONVALESCENCE; EBOLA HEMORRHAGIC FEVER; HEADACHE; HUMAN; MENINGOENCEPHALITIS; MENTAL HEALTH; NEUROLOGICAL COMPLICATION; NONHUMAN; PERSISTENT VIRUS INFECTION; RELAPSE; SEIZURE; SURVIVOR; VIRUS TRANSMISSION;

EID: 85017181612     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-017-0573-x     Document Type: Article

References (66)

1. Breman JG, Heymann DL, Lloyd G, McCormick JB, Miatudila M, Murphy FA, Muyembé-Tamfun JJ, Piot P, Ruppol JF, Sureau P, van der Groen G, Johnson KM. Discovery and description of Ebola Zaire virus in 1976 and relevance to the west African epidemic during 2013-2016. J Infect Dis. 2016;214(suppl 3):S93–S101.
2. World Health Organization. Ebola Situation Report 30 2016. Available from: http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016. Accessed November 15, 2016.
3. Baseler L, Chertow DS, Johnson KM, Feldmann H, Morens DM. The pathogenesis of Ebola virus disease. Annu Rev Pathol. 2017;12:387–418.
4. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol. 2015;235(2):153–74.
5. Paessler S, Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol. 2013;8:411–40.
6. Formenty P. Ebola Virus Disease. Emerging Infectious Diseases. 2014 Elsevier.
7. Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 2009;5:e1000536.
8. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature. 2005;438:575–6.
9. Groseth A, Feldman H, Strong JE. The ecology of Ebola virus. Trends Microbiol. 2007;15(9):408–16.
10. Plowright RK, Eby P, Hudson PJ, et al. Ecologic dynamics of emerging bat virus spillover. Proc Biol Sci. 2015;282(1798):20142124.
11. Shears P, O'Dempsey TJ. Ebola virus disease in Africa: epidemiology and nosocomial transmission. J Hosp Infect. 2015;90(1):1–9.
12. Brainard J, Hooper L, Pond K, Edmunds K, Hunter PR. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2015;20
13. Rewar S, Mirdha D. Transmission of ebola virus disease: an overview. Ann Glob Health. 2014;80(6):444–51.
14. Fischer WA, Uyeki TM, Tauxe RV. Ebola virus disease: what clinicians in the United States need to know. Am J Infect Control. 2015;43(8):788–93.
15. West TE. Von saint André-von Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc. 2014;11(9):1341–50.
16. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371(22):2054–7.
17. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78(8):4330–41.
18. Klompas M, Yokoe DS. The Ebola transmission paradox. Am J Infect Control. 2015;43(8):786–7.
19. Bechtelsheimer H, Korb G, Gedigk P. The “Marburg-virus”-hepatitis. Studies in man and guinea pigs. Virchows Arch A Pathol Pathol Anat. 1970;351:273–90.
20. Martini GA. Marburg virus disease. Postgrad Med J. 1973;49(574):542–6.
21. Baskerville A, Fisher-Hoch SP, Neild GH, Dowsett AB. Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol. 1985;147(3):199–209.
22. Larsen T, Stevens EL, Davis KJ, Geisbert JB, Daddario-DiCaprio KM, Jahrling PB, Hensley LE, Geisbert TW. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis. 2007;196(Suppl 2):S323–8.
23. • Alves DA, Honko AN, Kortepeter MG, Sun M, Johnson JC, Lugo-Roman LA, Hensley LE. Necrotizing Scleritis, conjunctivitis, and other pathologic findings in the left eye and brain of an EbolaVirus-infected rhesus macaque (Macaca mulatta) with apparent recovery and a delayed time of death. J Infect Dis. 2016;213(1):57–60. This study describes a nonhuman primate inoculated with Ebola virus which after a prolonged disease course displayed unusual pathological findings of delayed Ebola virus disease in the brain and eye.
24. WHO. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/international study team. Bull World Health Organ. 1978;56(2):247–70.
25. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis. 1999;179(Suppl 1):S1–7.
26. Sureau PH. Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis. 1989;11(Suppl 4):S790–3.
27. Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, Rwaguma EB, Kagwa P, Lamunu M. An outbreak of Ebola in Uganda. Tropical Med Int Health. 2002;7(12):1068–75.
28. Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala J, Yoti Z, Colebunders R, Palma PP, Sterk E, Jeffs B, Van Herp M, Borchert M. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One. 2012;7(12):e52986.
29. Ndambi R, Akamituna P, Bonnet MJ, Tukadila AM, Muyembe-Tamfum JJ, Colebunders R. Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S8–10.
30. Richards GA, Murphy S, Jobson R, Mer M, Zinman C, Taylor R, Swanepoel R, Duse A, Sharp G, De La Rey IC, Kassianides C. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med. 2000;28(1):240–4.
31. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, Garry RF, Lassa Fever Program KGH, Consortium VHF, WHO Clinical Response Team. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371(22):2092–100. doi:10.1056/NEJMoa1411680.
32. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, Shindo N, Fischer 2nd WA, Lamontagne F, Saliou SM, Bausch DG, Moumié B, Jagatic T, Sprecher A, Lawler JV, Mayet T, Jacquerioz FA, Méndez Baggi MF, Vallenas C, Clement C, Mardel S, Faye O, Faye O, Soropogui B, Magassouba N, Koivogui L, Pinto R, Fowler RA. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372(1):40–7. doi:10.1056/NEJMoa1411249.
33. Qin E, Bi J, Zhao M, Wang Y, Guo T, Yan T, Li Z, Sun J, Zhang J, Chen S, Wu Y, Li J, Zhong Y. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis. 2015;61(4):491–5. doi:10.1093/cid/civ319.
34. •• Chertow DS, Nath A, Suffredini AF,et al. Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report. Ann Intern Med. 2016 Apr 5. This case report describes a patient with acute Ebola virus disease who developed severe neurological manifestations. It is one of the only reports detailing MRI findings in a patient with recent recovery from EVD.
35. Sagui E, Janvier F, Baize S, et al. Severe Ebola virus infection with encephalopathy: evidence for direct virus involvement. Clin Infect Dis. 2015;61(10):1627–8.
36. de Greslan T, Billhot M, Rousseau C, et al. Ebola virus related encephalitis. Clin Infect Dis. 2016.
37. Howlett P, Brown C, Helderman T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis. Sierra Leone Emerg Infect Dis. 2016;22(1):150–2.
38. Dhillon P, McCarthy S, Gibbs M. Surviving stroke in an Ebola Treatment Centre. BMJ Case Rep. 2015;29:2015.
39. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis. 2010 5;4(10).
40. Chertow DS, Childs RW, Arai AE, Davey RT Jr. Cardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus Disease. JACC Cardiovasc Imaging. 2016.
41. Kibadi K, Mupapa K, Kuvula K, Massamba M, Ndaberey D, Muyembe-Tamfum JJ, Bwaka MA, De Roo A, Colebunders R. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis. 1999;179(Suppl 1):S13–4.
42. Wendo C. Caring for the survivors of Uganda's Ebola epidemic one year on. Lancet. 2001;358(9290):1350.
43. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999;179(Suppl 1):S28–35.
44. Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15(8):905–12.
45. Qureshi AI, Chughtai M, Loua TO, Pe Kolie J, Camara HF, Ishfaq MF, N'Dour CT, Beavogui K. Study of Ebola virus disease survivors in Guinea. Clin Infect Dis. 2015;61(7):1035–42.
46. Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-Ebola signs and symptoms in U.S. survivors. N Engl J Med. 2015;373(25):2484–6.
47. Mattia JG, Vandy MJ, Chang JC, Platt DE, Dierberg K, Bausch DG, Brooks T, Conteh S, Crozier I, Fowler RA, Kamara AP, Kang C, Mahadevan S, Mansaray Y, Marcell L, McKay G, O'Dempsey T, Parris V, Pinto R, Rangel A, Salam AP, Shantha J, Wolfman V, Yeh S, Chan AK, Mishra S. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16(3):331–8.
48. Tiffany A, Vetter P, Mattia J, Dayer JA, Bartsch M, Kasztura M, Sterk E, Tijerino AM, Kaiser L, Ciglenecki I. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis. 2016;62(11):1360–6.
49. Hereth He’bert E, Oury Bah M, E’tard JF, et al. Ocular complications in survivors of the Ebola outbreak in Guinea. Am J Ophthalmol. 2016 (16)30602-X.
50. Bowen L, Smith B, Steinbach S, Billioux BJ, et al. Survivors of Ebola Virus Disease have persistent neurologic deficits. 2016. Retrieved from: https://www.aan.com/PressRoom/Home/GetDigitalAsset/12003 [abstract].
51. Billioux BJ, Smith B, Nath A. Neurological complications of Ebola virus infection. Neurotherapeutics. 2016;13(3):461–70.
52. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S170–6.
53. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142–7.
54. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014;371(25):2394–401.
55. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371(25):2402–9.
56. Baggi FM, Taybi A, Kurth A, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surveill. 2014;19(49).
57. Biava M, Caglioti C, Bordi L, et al. Detection of viral RNA in tissues following plasma clearance from an Ebola virus infected patient. PLoS Pathog. 2017;13(1):e 1006065.
58. Deen GF, Knust B, Broutet N, et al. Ebola RNA persistence in semen of Ebola virus disease survivors—preliminary report. N Engl J Med. 2015:14.
59. Sissoko D, Duraffour S, Kerber R, et al. Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study. Lancet Glob Health. 2017;5(1):e80–8.
60. Etard JF, Sow MS, Leroy S, et al. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis. 2017 (16)30516–3.
61. Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med. 2015;373(25):2448–54.
62. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372(25):2423–7.
63. •• Jacobs M, Rodger A, Bell DJ, et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet. 2016 (16)30386–5. This case report describes the occurrence of a late relapse of Ebola virus disease occurring in the central nervous system; this case illustrates the potential of the CNS as a reservoir for Ebola virus.
64. Edwards JK, Kleine C, Munster V, Giuliani R, Massaquoi M, Sprecher A, Chertow DS. Interpretation of negative molecular test results in patients with suspected or confirmed Ebola virus disease: report of two cases. Open Forum Infect Dis. 2015;2(4):ofv137.
65. Billioux BJ, Smith B, Stavale E, Dorbor J, Wentworth D, Tarfeh-Burnette H, et al. Cerebrospinal fluid findings in Ebola survivors with neurological sequelae. Neurology. 2016;78:ES.003. (Meeting abstracts) Retrieved from: https://www.aan.com/uploadedFiles/Website_Library_Assets/Documents/7.Conferences/1.CONFERENCES/1.Annual_Meeting/1.Programs/2016-Emerging-Science-Onsite-Guide.pdf
66. Billioux BJ, Bowen L, Smith B, Steinbach S, Azodi S, Xie L, Bainda O, Moses JS, Nath A. Accounts from Liberia: reports of neurological manifestations during the acute phase of Ebola virus disease. Neurology. 2016;78:P1.283. (Meeting abstracts) Retrieved from:http://www.abstractsonline.com/pp8/#!/4046/presentation/6188